Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carson C Thoreen

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Biological Chemistry|January 20, 2009
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2011
Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stabilityQingsong Liu, Jinhua Wang, Seong A Kang, et al.
The Journal of Biological Chemistry|March 1, 2020
Correction: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
Development of ATP-competitive mTOR inhibitorsQingsong Liu, Seong A Kang, Carson C Thoreen, et al.
Journal of Medicinal Chemistry|September 24, 2010
Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancerQingsong Liu, Jae Won Chang, Jinhua Wang, et al.
Cancer Research|December 4, 2016
ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAPTaru Muranen, Laura M Selfors, Julie Hwang, et al.
Genome Research|January 18, 2011
Genome-scale RNAi on living-cell microarrays identifies novel regulators of Drosophila melanogaster TORC1-S6K pathway signalingRobert A Lindquist, Kathleen A Ottina, Douglas B Wheeler, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Cancer Research|February 26, 2013
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATRQingsong Liu, Chunxiao Xu, Sivapriya Kirubakaran, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Biological Chemistry|January 20, 2009
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2011
Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stabilityQingsong Liu, Jinhua Wang, Seong A Kang, et al.
The Journal of Biological Chemistry|March 1, 2020
Correction: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
Development of ATP-competitive mTOR inhibitorsQingsong Liu, Seong A Kang, Carson C Thoreen, et al.
Journal of Medicinal Chemistry|September 24, 2010
Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancerQingsong Liu, Jae Won Chang, Jinhua Wang, et al.
Cancer Research|December 4, 2016
ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAPTaru Muranen, Laura M Selfors, Julie Hwang, et al.
Genome Research|January 18, 2011
Genome-scale RNAi on living-cell microarrays identifies novel regulators of Drosophila melanogaster TORC1-S6K pathway signalingRobert A Lindquist, Kathleen A Ottina, Douglas B Wheeler, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Cancer Research|February 26, 2013
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATRQingsong Liu, Chunxiao Xu, Sivapriya Kirubakaran, et al.
Pageof 4